Lv5
1260 积分 2023-10-29 加入
Refractory psoriatic arthritis: emerging concepts in whole process management
3天前
已完结
Unraveling the Challenges of Difficult-to-Treat Spondyloarthritis: SPARTAN 2024 Annual Meeting Proceedings
3天前
已完结
The steroid-sparing effect of JAK inhibitors across multiple patient populations
3天前
已完结
Potential difficult-to-treat psoriatic arthritis real-world prevalence and contributing factors
3天前
已完结
Difficult-to-Treat Axial Spondyloarthritis: A New Challenge
3天前
已完结
Can we define difficult-to-treat systemic sclerosis?
3天前
已完结
Difficult-to-treat axial spondyloarthritis patients
3天前
已完结
Is the Difficult-to-Treat (D2T) concept applicable to axial spondyloarthritis?
3天前
已完结
Efficacy and safety of selective TYK2 inhibitor, deucravacitinib, in a phase II trial in psoriatic arthritis
19天前
已完结
GRAPPA 2021 Treatment Recommendations for Psoriatic Arthritis
19天前
已关闭
皖公网安备34019202002308
